ASCO 2026 – oral abstracts

We are proud to share that two EMN studies have been accepted as Oral Presentations at the ASCO Annual Meeting in Chicago this year!
🔹 The abstract from the EMN34 study in the high-risk smoldering myeloma setting, led by Cyrille Touzeau
🔹 The analysis from the EMN17 study applying the new IMS/IMWG risk criteria using NGS, coordinated by Luca Bertamini

Congratulations to the lead authors and a sincere thank you to all participating centers – and above all to the patients who contributed to these studies.

We look forward to sharing these important results at the congress on 29 May. Don’t miss the presentations at ASCO!